Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,609 signal articles · 109 in last 24h · 155,480 total before filter · latest 1h ago
109last 24h
848last 7d
142● bullish (7d)
90● bearish (7d)
214publishers
AllMacro191Earnings105M&A123Regulatory20Product22Analyst19
✕ clear all filterssentiment: bullishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead
StockStory14d agobullish
2 Reasons to Avoid JAZZ and 1 Stock to Buy Instead

Jazz Pharmaceuticals’s 29.7% return over the past six months has outpaced the S&P 500 by 17%, and its stock price has climbed to $240.49 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Did Repeat Buyers Tell You CrowdStrike Stock Would Run?
Trefis14d agobullish
Did Repeat Buyers Tell You CrowdStrike Stock Would Run?

CrowdStrike (CRWD) stock rose about 97% over the past year, against 18% for the S&P 500, as growth in the recurring revenue it adds each quarter sped up. Management was forecasting that speed-up by March 2025 and named one mechanism: Falcon Flex customers using up their contracts early and coming back for more. The direction was public. The size of the fiscal 2027 speed-up was not.